A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for...
Patients with hepatitis C virus (HCV) have a higher prevalence of comorbidities and multimorbidity compared with the general population, according to a study published in BMC Infectious Diseases. In this retrospective...
British scientists say a common virus that causes childhood coughs and colds could be key in developing future treatments for primary liver cancer and hepatitis C. Researchers at University of Leeds found that a...
Virus induces liver cells to make molecules that inhibit production of a key immune signaling receptor. The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells...
Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute (TSRI) have discovered one reason why success has so...
An international team of researchers has shed light on the potential impact of new drugs for hepatitis C virus (HCV). HCV is an important cause of liver cancer and is transmitted through blood to blood contact. People...
A combined vaccination against Hepatitis C virus (HCV) and HIV moved a step closer, with the results of a study* presented at The International Liver Congress™ 2016 in Barcelona, Spain. An estimated 2.3 million people...
A group of Indian scientists has developed a vaccine meant to treat Hepatitis C, a virus or infection that causes liver disease and inflammation of the liver. According to the report in Times of India, the team from the...
A recent trial shows that interferon-free therapy has cleared hepatitis C from 93 percent of the patients involved in the trial. The investigational three-drug hepatitis C combination treatment required 12 weeks of...
A prophylactic hepatitis C virus (HCV) vaccine produces a long-lasting, sustained T-cell response that is characteristic of the T-cell response associated with a controlled HCV infection. Researchers have evaluated the...